Display options
Cite
Luis-Gronau C, Cruzval-O'Reilly E, Lugo-Somolinos A. Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance. Dermatitis. 2021;32(6):e135-e136doi: 10.1097/DER.0000000000000736.
Luis-Gronau, C., Cruzval-O'Reilly, E., & Lugo-Somolinos, A. (2021). Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance. Dermatitis : contact, atopic, occupational, drug, 32(6), e135-e136. https://doi.org/10.1097/DER.0000000000000736
Luis-Gronau, Camila, et al. "Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance." Dermatitis : contact, atopic, occupational, drug vol. 32,6 (2021): e135-e136. doi: https://doi.org/10.1097/DER.0000000000000736
Luis-Gronau C, Cruzval-O'Reilly E, Lugo-Somolinos A. Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance. Dermatitis. 2021 Nov-Dec 01;32(6):e135-e136. doi: 10.1097/DER.0000000000000736. PMID: 34807540.
Copy Download .nbib Format: NLM
Share it on

Dermatitis. 2021 Nov-Dec 01;32(6):e135-e136. doi: 10.1097/DER.0000000000000736.

Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance.

Dermatitis : contact, atopic, occupational, drug

Camila Luis-Gronau, Estefanía Cruzval-O'Reilly, Aída Lugo-Somolinos

PMID: 34807540 DOI: 10.1097/DER.0000000000000736

[No abstract available.]

Conflict of interest statement

The authors have no funding or conflicts of interest to declare.

References

  1. Schalock PC, Dunnick CA, Nedorost S, et al.; American Contact Dermatitis Society Core Allergen Series Committee. American Contact Dermatitis Society Core Allergen Series: 2020 update. Dermatitis 2020;31(5):279–282. - PubMed
  2. Scheman A, Patel KR, Roszko K, et al. Relative prevalence of contact allergens in North America in 2018. Dermatitis 2020;31(2):112–121. - PubMed

Publication Types